These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1213 related articles for article (PubMed ID: 28560287)

  • 1. Mend Your Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease.
    Martini E; Krug SM; Siegmund B; Neurath MF; Becker C
    Cell Mol Gastroenterol Hepatol; 2017 Jul; 4(1):33-46. PubMed ID: 28560287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of Intestinal Epithelial Barrier Dysfunction by Adherent-Invasive
    Shawki A; McCole DF
    Cell Mol Gastroenterol Hepatol; 2017 Jan; 3(1):41-50. PubMed ID: 28174756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease.
    Jergens AE; Parvinroo S; Kopper J; Wannemuehler MJ
    Front Med (Lausanne); 2021; 8():669913. PubMed ID: 34513862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal epithelium in inflammatory bowel disease.
    Coskun M
    Front Med (Lausanne); 2014; 1():24. PubMed ID: 25593900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation.
    Luettig J; Rosenthal R; Barmeyer C; Schulzke JD
    Tissue Barriers; 2015; 3(1-2):e977176. PubMed ID: 25838982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of Intestinal Epithelial Cell RIPK Pathways Promotes Chronic Inflammation in the IBD Gut.
    Garcia-Carbonell R; Yao SJ; Das S; Guma M
    Front Immunol; 2019; 10():1094. PubMed ID: 31164887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleiotropic functions of TNF-α in the regulation of the intestinal epithelial response to inflammation.
    Leppkes M; Roulis M; Neurath MF; Kollias G; Becker C
    Int Immunol; 2014 Sep; 26(9):509-15. PubMed ID: 24821262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate and adaptive immunity in inflammatory bowel disease.
    Geremia A; Biancheri P; Allan P; Corazza GR; Di Sabatino A
    Autoimmun Rev; 2014 Jan; 13(1):3-10. PubMed ID: 23774107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy.
    Merga Y; Campbell BJ; Rhodes JM
    Dig Dis; 2014; 32(4):475-83. PubMed ID: 24969297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis.
    Su L; Shen L; Clayburgh DR; Nalle SC; Sullivan EA; Meddings JB; Abraham C; Turner JR
    Gastroenterology; 2009 Feb; 136(2):551-63. PubMed ID: 19027740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic therapy for inflammatory bowel disease.
    Ardizzone S; Bianchi Porro G
    Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic options to modulate barrier defects in inflammatory bowel disease.
    Hering NA; Schulzke JD
    Dig Dis; 2009; 27(4):450-4. PubMed ID: 19897959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-200b inhibits TNF-α-induced IL-8 secretion and tight junction disruption of intestinal epithelial cells in vitro.
    Shen Y; Zhou M; Yan J; Gong Z; Xiao Y; Zhang C; Du P; Chen Y
    Am J Physiol Gastrointest Liver Physiol; 2017 Feb; 312(2):G123-G132. PubMed ID: 27979826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
    He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
    Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epithelial cell in intestinal homeostasis and inflammatory bowel diseases].
    Zouiten-Mekki L; Serghini M; Fekih M; Kallel L; Matri S; Ben Mustapha N; Boubaker J; Filali A
    Med Sci (Paris); 2013 Dec; 29(12):1145-50. PubMed ID: 24356146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.
    Kucharzik T; Walsh SV; Chen J; Parkos CA; Nusrat A
    Am J Pathol; 2001 Dec; 159(6):2001-9. PubMed ID: 11733350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier.
    Ye D; Ma I; Ma TY
    Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G496-504. PubMed ID: 16474009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation.
    Garg A; Zhao A; Erickson SL; Mukherjee S; Lau AJ; Alston L; Chang TK; Mani S; Hirota SA
    J Pharmacol Exp Ther; 2016 Oct; 359(1):91-101. PubMed ID: 27440420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease-Focusing on Intestinal Barrier Function.
    Schoultz I; Keita ÅV
    Cells; 2019 Feb; 8(2):. PubMed ID: 30813280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.